We hypothesize that cervical interleukin-6 (IL-6) concentrations, assessed during the expectant management of PPROM, exhibit a stronger correlation with early neonatal inflammatory markers (CRP and PCT) than with maternal serum parameters. This evidence concerns the gene IL6 and preterm premature rupture of the membranes.